Oncology/Hematology
Breast Cancer
More in Breast Cancer
Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease
Oct 10, 2024
Trial finds similar complication and recurrence rates with hypofractionated versus standard RT
Oct 01, 2024
Numerical advantage in randomized trial, non-randomized study misses noninferiority mark
Oct 01, 2024
Study suggests differences in how the ACA cost-sharing exemption is applied across patient groups
Sep 27, 2024